NCT06681636View on ClinicalTrials.gov

Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

December 14, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2027

Conditions
HPV InfectionCervical CancerAnogenital CancerAnogenital Warts
Interventions
BIOLOGICAL

Human papillomavirus 9-valent vaccine, Recombinant

HPV vaccine manufactured by MSD consisted of 9HPV types: 6,11,16,18,31,33, 45, 52,58

Trial Locations (3)

3052

Murdoch Children Research Institute, Parkville

180000

Center for Supporting Community Development Initiatives SCDI-Vietnam, Haiphong

Hai Phong Center for Disease Control, Haiphong

Sponsors
All Listed Sponsors
collaborator

Murdoch Childrens Research Institute

OTHER

collaborator

CENTER FOR SUPPORTING COMMUNITY DEVELOPMENT INITIATIVES

UNKNOWN

collaborator

Hai Phong Center for Disease Control

OTHER_GOV

lead

National Institute of Hygiene and Epidemiology, Vietnam

OTHER